Understanding the complexities of Parkinson's Disease (PD) is crucial for healthcare professionals. As the second most common neurodegenerative disorder, it presents unique challenges in diagnosis and management.
PD is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to a disruption in the balance of dopamine and acetylcholine. This imbalance results in the cardinal motor symptoms of PD: bradykinesia, tremor, rigidity, and postural instability.
Motor symptoms are often the initial presentation, but non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction are common. As the disease progresses, motor symptoms may become more prominent and disabling.
Diagnosis is primarily clinical, based on history and physical examination. Neuroimaging, while not routinely used, can support the diagnosis in uncertain cases. Biomarkers are an area of active research but are not currently used in clinical practice.
Treatment is symptomatic and includes pharmacological and non-pharmacological interventions. Levodopa remains the most effective medication for motor symptoms. Non-pharmacological interventions include physical therapy, occupational therapy, and speech therapy.
PD is a progressive disease with variable rates of progression. Factors influencing prognosis include age at onset, severity of symptoms, and presence of comorbidities. While there is currently no cure, treatments can significantly improve quality of life.
In conclusion, PD is a complex neurodegenerative disorder requiring a comprehensive approach to diagnosis and management. As healthcare professionals, it is essential to stay abreast of the latest research and treatment options to provide the best care for our patients.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation